Genufood Energy Enzymes Corp.
GFOO
$0.0003
$0.000150.00%
| Weiss Ratings | GFOO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | GFOO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | GFOO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -8.63 | |||
| Price History | GFOO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 50.00% | |||
| 90-Day Total Return | 50.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -96.51% | |||
| 2-Year Total Return | -98.80% | |||
| 3-Year Total Return | -98.80% | |||
| 5-Year Total Return | -99.25% | |||
| 52-Week High % Change | -96.51% | |||
| 52-Week Low % Change | 50.00% | |||
| Price | GFOO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.01 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Oct 16, 2024 | |||
| 52-Week High Price (Date) | Mar 28, 2024 | |||
| Valuation | GFOO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 242.67K | |||
| Enterprise Value | 223.05K | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -23.08% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -- | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -0.59 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | GFOO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 808.90M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | GFOO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 855 707 2077 | |||
| Address | 1108 S. Baldwin Avenue Arcadia, CA 91007 | |||
| Website | www.geecenzymes.com | |||
| Country | United States | |||
| Year Founded | 2010 | |||
| Profitability | GFOO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | GFOO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -246.61% | |||
| Return on Equity | -- | |||
| Income Statement | GFOO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -378.80K | |||
| Net Income (TTM) | -576.00K | |||
| Net Income Avl. to Common (TTM) | -576.00K | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 34.58% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | 80.00% | |||
| Balance Sheet | GFOO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 19.60K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 27.60K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -25.50K | |||
| Current Ratio (Q) | 0.237 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 123.80K | |||
| Total Current Liabilities (Q) | 116.30K | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 149.30K | |||
| Total Common Equity (Q) | -25.50K | |||
| Cash Flow | GFOO - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -81.20K | |||
| Cash from Financing (TTM) | 362.00K | |||
| Net Change in Cash (TTM) | -26.90K | |||
| Levered Free Cash Flow (TTM) | -382.10K | |||
| Cash from Operations (TTM) | -307.70K | |||
